Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
The Insulin Delivery Devices Market is Set to Grow at a CAGR of 6% to Reach $11 Billion by 2017
GlobalData estimated the global insulin delivery devices market at $7.4 billion in 2010. Driven by the significant increase in prevalence of diabetes; the availability of reimbursement for insulin delivery devices and positive clinical outcomes from studies, the market is forecast to grow at a Compound Annual Growth Rate (CAGR) of 6% to exceed $11 billion in 2017.
The US is the largest insulin delivery devices market. The US insulin delivery devices market was valued at $2.8 billion in 2010 and is expected to grow at a CAGR of 6% to reach $4.2 billion by 2017. The growth will be fuelled by a number of factors, such as the increase in the incidence of diabetes among all ages, higher market penetration of insulin pumps and the availability of reimbursement.
http://www.prnewswire.com/news-rele...f-diabetes-to-drive-the-market-137330083.html
GlobalData estimated the global insulin delivery devices market at $7.4 billion in 2010. Driven by the significant increase in prevalence of diabetes; the availability of reimbursement for insulin delivery devices and positive clinical outcomes from studies, the market is forecast to grow at a Compound Annual Growth Rate (CAGR) of 6% to exceed $11 billion in 2017.
The US is the largest insulin delivery devices market. The US insulin delivery devices market was valued at $2.8 billion in 2010 and is expected to grow at a CAGR of 6% to reach $4.2 billion by 2017. The growth will be fuelled by a number of factors, such as the increase in the incidence of diabetes among all ages, higher market penetration of insulin pumps and the availability of reimbursement.
http://www.prnewswire.com/news-rele...f-diabetes-to-drive-the-market-137330083.html
